Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Doxorubicin vs Doxorubicin + Ifosfamide in Advanced Soft Tissue Sarcoma
NCT00061984Phase 3Completed
- Sponsor
- European Organisation for Research and Treatment of Cancer
- Start
- Apr 2003
- Primary completion
- May 2010
- Modality
- Small Molecules
- Countries
- 11
01
Overview
Phase 3, randomised, open-label trial of ifosfamide in soft tissue sarcoma (STS) (2 arms), sponsored by European Organisation for Research and Treatment of Cancer. Primary endpoint: Overall Survival. Started Apr 2003; status: completed.
02
Drugs
ifosfamide
03
Conditions
soft tissue sarcoma (STS)
Beyond the preview
Go deeper on NCT00061984.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00061984.